FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a method for predicting an effective dose of 5-hydroxy-1H-imidazole-4-carboxamide, or a pharmaceutically acceptable salt thereof, or a hydrate thereof for a patient with myelodysplastic syndrome. Invention also relates to a method for predicting the susceptibility of said patient to treatment with 5-hydroxy-1H-imidazole-4-carboxamide, or a pharmaceutically acceptable salt thereof, or a hydrate thereof. In addition, the invention relates to a method for determining the amount of xanthosine monophosphate in whole blood for use in the methods of the invention. Among other things, the invention relates to a kit for predicting an effective dose of 5-hydroxy-1H-imidazole-4-carboxamide, or a pharmaceutically acceptable salt thereof, or a hydrate thereof for said patient; and a kit for predicting the susceptibility of said patient to treatment with 5-hydroxy-1H-imidazole-4-carboxamide, or a pharmaceutically acceptable salt thereof, or a hydrate thereof.
EFFECT: invention makes it possible to distinguish quantitatively impurities and xanthosine monophosphate in whole blood.
24 cl, 19 tbl, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 4-(SELENOPHEN-2(OR 3)-YLAMINO) PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF | 2011 |
|
RU2597609C2 |
SUBSTITUTED 4-(ARYLAMINO) SELENOPHENOPYRIMIDINE COMPOUNDS AND METHODS OF THEREOF APPLICATION | 2011 |
|
RU2566293C2 |
2,6-SUBSTITUTED-4-MONOSUBSTITUTED AMINOPYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2007 |
|
RU2431631C2 |
6-[4-(1H-IMIDAZOL-2-YL)PIPERIDIN-1-YL]PYRIMIDIN-4-AMINE DERIVATIVES AS MODULATORS OF KINASE ACTIVITY | 2014 |
|
RU2674261C2 |
SULPHONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES | 2012 |
|
RU2606639C2 |
COMPOUNDS AND METHODS FOR TREATMENT OF PARASITIC DISEASES | 2018 |
|
RU2793122C2 |
CAPSID PROTEIN ASSEMBLY INHIBITOR CONTAINING N-HETEROCYCLIC FIVE-MEMBERED RING, ITS PHARMACEUTICAL COMPOSITION AND USE | 2019 |
|
RU2802259C2 |
QUINAZOLINE COMPOUNDS | 2011 |
|
RU2530887C2 |
ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 2012 |
|
RU2632193C2 |
AMINOACYL DERIVATIVES AS PRODRUGS AND PREPARATIONS FOR TREATING THROMBOEMBOLIC DISEASES | 2007 |
|
RU2456283C9 |
Authors
Dates
2018-11-20—Published
2015-01-09—Filed